• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

NovoCure

Novocure sinks on missed Q4 projections

February 24, 2022 By Sean Whooley

Novocure (NSDQ:NVCR) shares took a sharp dip on fourth-quarter results that came up short of the consensus forecast. NVCR shares were down 12.7% at $63.70 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 1.3%. The St. Helier, Jersey-based company […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Oncology, Wall Street Beat Tagged With: NovoCure

These medtech companies care a lot about research

January 19, 2022 By Chris Newmarker

They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Cardiovascular, Diabetes, Featured, Neuromodulation/Neurostimulation, News Well, Oncology, Optical/Ophthalmic, Research & Development Tagged With: AtriCure Inc., Big 100, Dexcom, Glaukos, Inspire Medical Systems Inc., NovoCure

Novocure signs agreement to build development facility in New Hampshire

December 8, 2021 By Sean Whooley

Novocure (NSDQ:NVCR) announced today that it signed a purchase and sale agreement for an office building in Portsmouth, New Hampshire. The agreement covers the acquisition and construction of the building at 64 Vaughan Mall, situated centrally in downtown Portsmouth. The purchase price for the property totals $9.5 million and, after closing (expected on or before […]

Filed Under: Business/Financial News, Featured, Oncology, Radiosurgery/Radiation therapy Tagged With: NovoCure

How medtech fared in the first waves of the pandemic

November 18, 2021 By Danielle Kirsh

Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data. Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial […]

Filed Under: Business/Financial News, Featured Tagged With: Ambu, Bio-Rad, biomerieux, Cardiovascular Systems, Centers for Medicare and Medicaid Services, danaher, Dexcom, Dräger, Fisher & Paykel Healthcare, Getinge, Insulet, Invacare, Konica Minolta, Masimo, Medtronic, Montagu Private Equity, Nevro Corp., NovoCure, Olympus, ResMed, RTI Surgical, Surgalign

Novocure slides on Q3 earnings, revenue misses

October 28, 2021 By Sean Whooley

Novocure (NSDQ:NVCR) shares slid this morning on third-quarter results that fell short the consensus forecast. NVCR shares were down -7.3% at $102.68 per share in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained virtually unchanged. The St. Helier, Jersey-based developer of electric fields for […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Oncology, Wall Street Beat Tagged With: NovoCure

Novocure wins FDA breakthough designation for liver tumor treatment device

September 9, 2021 By Sean Whooley

Novocure (NSDQ:NVCR) announced today that the FDA granted breakthrough designation for its NovoTTF-200T liver cancer treatment system. St. Helier, Jersey-based Novocure designed its NovoTTF-200T system, a tumor treating fields (TTFields) delivery system for use in tandem with atezolizumab and bevacizumab for the first-line treatment of patients with unresectable or metastatic liver cancer. According to a […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: FDA, NovoCure

Novocure plummets on missed Q2 projections

July 29, 2021 By Sean Whooley

Novocure (NSDQ:NVCR) shares took a dive today on second-quarter results that came up short of the consensus forecast. NVCR shares were down -11.7% at $160.67 in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.9% on the day. Get the full story at our sister […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Oncology, Wall Street Beat Tagged With: NovoCure

MedTech 100 roundup: Stocks show no signs of slowing down

November 9, 2020 By Sean Whooley

The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: BioNTech, coronavirus, COVID-19, Hologic, Inspire Medical Systems Inc., Livongo, MedTech 100 Index, Mesa Biotech, NovoCure, Oxford University, Pfizer, Stryker, Teladoc, transmedics

Novocure closes $575M offering

November 6, 2020 By Sean Whooley

NovoCure (NSDQ:NVCR) announced that it closed its previously announced offering of $575 million in 0% convertible senior notes. The notes, due in 2025, are set to bring in net proceeds of approximately $558.4 million after the initial purchasers exercised full their option to purchase an additional $75 million in notes, according to a news release from […]

Filed Under: Business/Financial News, Funding Roundup, Oncology Tagged With: NovoCure

COVID-19 upends medtech’s financial outlook

April 7, 2020 By Sean Whooley

The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]

Filed Under: Business/Financial News, Cardiovascular, Clinical Trials, Contract Manufacturing, Diabetes, Diagnostics, Featured, Genomics/Molecular Diagnostics, Health Technology, Imaging, Implants, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Check-Cap, coronavirus, COVID-19, Cutera Inc., Endologix, Hologic, Iradimed Corp, Livongo, Myomo Inc, Natus Medical Inc., NovoCure, Penumbra Inc., Shockwave Medical, Silk Road Medical Inc., Zynex

Novocure’s Optune wins innovative medical device designation from China

August 13, 2019 By Danielle Kirsh

NovoCure (NSDQ:NVCR) said today that it was granted Innovative Medical Device Designation in China for its Optune tumor treating system. The Optune system uses electric fields that are tuned in to specific frequencies to disrupt cancer cell division, according to the company. The technology inhibits tumor growth and causes cancer cells to die. Zai Lab has […]

Filed Under: Oncology, Regulatory/Compliance Tagged With: NovoCure

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS